NH SPAC 8 (218410) fair value: what the stock is really worth
As of Nov 6, 2026: fair value (intrinsic value) of NH SPAC 8 stock KRW 40,920, price KRW 37,200, upside +10.0%, quality 68 out of 100. Rating: fairly valued. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.
69 individual criteria per stock, every one traceableSee the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year. As of Nov 7, 2026.
How to read this chart
60‑month range 10,445 KRW – 112,500 KRW · fair‑value band 27,072 KRW – 53,953 KRW · the 37,200 KRW price screens below the 40,920 KRW fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). 1 fiscal year is left out: there the valuation rested on only a fraction of the usual models. As of Nov 7, 2026.
Follow NH SPAC 8 in your weekly email
Every Wednesday you see whether NH SPAC 8 is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
RFHIC Corporation designs and manufactures radio frequency (RF) and microwave components for wireless infrastructure, commercial and military radar, and industrial/scientific/medical industries in South Korea and internationally.
Show moreShow less
The company's products include RF power transistors comprising gallium nitride (GaN) on SiC transistors; GaN and GaAs MMICs, and active dividers; power amplifiers, such as hybrid, pallet, wideband, module, and low noise amplifiers, as well as GaN T/R modules; and sub-systems, including RF/microwave generators, RF transmitters, and high-power combiners.
It offers its products for telecommunications application, such as 4G LTE, 5G, Wi-Fi, point-to-point radio, and SatCom; RF energy applications, including microwave heating and drying, particle accelerators, plasma lighting, semiconductor equipment, waste gasification, carbon fiber and composite materials, microwave assisted X-ray laser, microwave tumor ablation, and bio and health sciences; and defense applications comprising radar, milcom, electronic warfare, and SatCom/VSAT. The company was founded in 1999 and is headquartered in Anyang-si, South Korea.
Stock analysis
NH SPAC 8 (218410) currently trades at 37,200 KRW, while our model-based Fair Value estimate is 40,920 KRW, so the stock looks roughly fairly valued today (gap 9.1%).
Show more
Valuation
Bull case: the Multiples group reads highest at a median of 29,891 KRW per share, and 2 of the 26 models we run sit above the 37,200 KRW price.
Bear case: the Economic Profit group reads lowest at 13,361 KRW, and 24 of the 26 models stay below the price. Data coverage for this calculation is medium.
Scenario range: 27,072 KRW (bear) to 53,953 KRW (bull), the price of 37,200 KRW sits inside it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 68/100 (solid quality), in the Technology sector.
Healthy Growth: Revenue growth appears healthy and is supported by profitability and cash-flow quality.
NH SPAC 8 reported revenue of 186B KRW in FY2025 versus 102B KRW in FY2021, a compound +16.3%/yr. Reported net income was 28.7B KRW in FY2025, compounding +47.7%/yr from FY2021.
Key figures
Market cap 1.2T KRW (≈ $879M) Small · P/S ratio 11.2 · Dividend yield 0.5% · Net margin 4.2% · Return on equity 245% · Return on assets (EBIT) 1.3% (5-year average) · Operating margin 1.0% · Revenue (TTM) 107B KRW.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 51 out of 100 (low confidence).
What moves the price
The share trades about 67% below its 52-week high and 45% above its 52-week low, currently below its 200-day average.
For context, the median of 10 Technology peers we cover trades at 4% fair-value upside, at 10%, 218410 screens cheaper than that median.
Fair Value models
Bear27,072 KRWFair Value 40,920 KRWBull53,953 KRW
Price 37,200 KRW · Upside +10.0%
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above starts from their evidence-weighted blend, not from a single model. In cyclical trough or peak years, after dilution or a stock split it is adjusted afterwards, so it can sit above or below the models.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds.Coverage ⓘCoverage = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.95/100
Revenue growth appears healthy and is supported by profitability and cash-flow quality.
Revenue growth 1 year
+61.7%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+19.8%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+21.4%
Start year 2020 (pandemic)
Revenue growth 9 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+13.1%
’16
’17
’18
’19
’20
’21
’22
’23
’24
’25
What shareholders gained per year (last 5 years), in KRW (mathematically smoothed) ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate. Smoothed = median of all growth paths between the years of the window (trend line on the logarithm of earnings per share): a single extreme year cannot distort the rate. The reported figure stays in the tooltip. Measured in KRW: this currency has depreciated against the euro and dollar over the long run, so part of the nominal rate is currency erosion that never reaches a EUR/USD investor.
+69.0%
Earnings growth per share plus dividend.
Earnings per share, growth per year+68.5%
Dividend (yield on the price)0.5%
Pace: 5 vs 10 years ⓘTwo data points, not a trend model: earnings growth per share over the last 5 fiscal years against the last 10. Labelled "steady" when both rates are within 3 percentage points of each other, otherwise picking up or flattening. Shown only when ten years of history exist.37.5% vs 28.8%, picking up
Profit margin 2020 to 2025 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.−4% → 17%
2025 sits 68% above its own trend. The rate follows the median trend of the last 5 years, not that single year.
Pace: the 5-year rate starts in 2020 (pandemic)
Growth Forecast
Little optimism in the price
The price assumes about as much growth as the company has delivered so far and less than analysts expect.
What the price assumes ⓘThis turns our valuation around: instead of asking what the share is worth, it asks what growth the current price requires. It uses the cash the company keeps after all spending (free cash flow), the same discount rate as our models, five years of growth, then slowing evenly to 2 % a year by year ten. Compared with the analysts' sales forecasts extended to the same five years (at least three analysts, for context only, it does not enter the Fair Value): within 3 percentage points counts as "in line" (amber), below that little optimism (green), above that a lot of optimism (red).
+20.1%
Yearly growth needed for the next five years to justify today's price.
What forecasts expect ⓘAnalysts publish sales forecasts for the next two fiscal years. For the years after that, growth slows evenly to 2 % a year by year ten (2 % is the long-run rate our models use). Projected years are marked as such.
+33.1%
Yearly sales growth analysts expect, extended to five years.
After inflation (South Korea: IMF forecast 2.1% a year to 2030, 2.1% from 2016 to 2025) that is about +17.6% a year for the price and +30.4% for the forecasts.
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Semiconductors & Semiconductor Equipment · 48 stocks
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
As of Nov 7, 2026, our model estimates a fair value of 40,920 KRW versus a price of 37,200 KRW, about +10% upside (fairly valued).
What is the fair value of 218410?
Our model-based fair value for NH SPAC 8 is 40,920 KRW (as of Nov 7, 2026), built from audited fundamentals. The current price: 37,200 KRW.
What is the quality score of 218410?
NH SPAC 8 has a Quality Score of 68/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for NH SPAC 8 (218410)?
Our model-based price target is the fair value of 40,920 KRW (as of Nov 7, 2026) from 26 valuation models. Cautious scenario 27,072 KRW, optimistic scenario 53,953 KRW. It is a calculation from audited fundamentals, not an analyst target.
What is the NH SPAC 8 stock forecast for 2026?
Our models put fair value at 40,920 KRW, about +10% upside versus a price of 37,200 KRW (fairly valued). Cautious scenario 27,072 KRW, optimistic scenario 53,953 KRW. The calculation is refreshed regularly with new filings.
What is the revenue of NH SPAC 8 (218410)?
NH SPAC 8 reported trailing-twelve-month revenue of about 107B KRW (latest available figure, as of Nov 7, 2026).
Does NH SPAC 8 pay a dividend?
NH SPAC 8 currently shows a dividend yield of 0.46% relative to its recent price (as of Nov 7, 2026).
How much is the dividend of NH SPAC 8 (218410)?
NH SPAC 8 has a dividend yield of 0.5%. A dividend has been paid every year since at least 2017. Our assessment: Safety not assessed. Payout ratio and cash coverage are not available, so we do not judge how safe this dividend is.
What growth is priced into NH SPAC 8 (218410)?
For today's price to be fair in a discounted-cash-flow model, NH SPAC 8 would have to grow free cash flow by +20.1 % per year for five years (discount rate 10.2 %, then slowing evenly to 2 % perpetual growth by year ten). Over the last 5 years revenue grew +21.4 % per year. As of Nov 7, 2026.
What discount rate (WACC) does the fair value of 218410 use?
Our models discount NH SPAC 8 at 10.2 %: a base by market capitalisation (small), damped by beta 0.47, country premium for South Korea. The same rate applies in all 26 models.
What is a reverse DCF?
A reverse DCF turns the usual calculation around. Instead of deriving a value from assumptions, it takes today's price as given and asks: what free-cash-flow growth would a company have to deliver for exactly this price to be fair? The result is not a forecast but the expectation already priced in. For NH SPAC 8 that is +20.1 % per year for five years, then slowing evenly to 2 % by year ten, using the same discount rate (10.2 %) and the same formula as our fair value.
How much growth has NH SPAC 8 (218410) delivered so far?
Over the past 5 years revenue at NH SPAC 8 grew +21.4 % a year. The price currently implies free-cash-flow growth of +20.1 % per year. Comparing the two shows how much confidence is in the price: if it demands more than has been delivered, the business has to accelerate for the maths to work.
How fast is the sector of NH SPAC 8 (218410) growing?
The median revenue growth in the sector is +11.5 % a year. That is the yardstick for the growth priced into NH SPAC 8 (+20.1 % per year): it shows whether the expectation is within the usual range or beyond it.
What is the free cash flow yield of NH SPAC 8 (218410)?
The free-cash-flow yield on the price is 2.58 %: that much free cash flow NH SPAC 8 produces per unit of market value. When it exceeds the discount rate of our models (10.2 %), the business already earns more than its cost of capital demands, and the price needs little additional growth.
What is the intrinsic value of NH SPAC 8 (218410)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For NH SPAC 8 it is 40,920 KRW per share (as of Nov 7, 2026), against a price of 37,200 KRW. It is the blended result of 26 valuation models in 8 families (DCF Models, Earnings-Based, Dividend Discount, Multiples, Asset-Based, Growth DCF, Economic Profit, Growth Earnings).
Is NH SPAC 8 stock overvalued or undervalued in 2026?
As of Nov 7, 2026, 218410 trades below its calculated fair value: price 37,200 KRW, fair value 40,920 KRW, a gap of about +10% (fairly valued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of 218410?
No. The price is what the market pays today (37,200 KRW); the fair value is what the company's own numbers justify (40,920 KRW). For NH SPAC 8 the two are 3,720 KRW per share apart. That gap is exactly why we show both numbers side by side.
How much is NH SPAC 8 worth?
The market values NH SPAC 8 at about 1.2T KRW (market capitalisation, as of Nov 7, 2026). Per share that is 37,200 KRW; our models calculate a fair value of 40,920 KRW per share.
What do the bullish and bearish scenarios say about 218410?
Our models span a range for NH SPAC 8: cautious scenario 27,072 KRW, base 40,920 KRW, optimistic 53,953 KRW per share (as of Nov 7, 2026, price 37,200 KRW). The range comes from different growth and margin assumptions, not from analyst opinions.
How solid is the balance sheet of NH SPAC 8 (218410)?
Balance-sheet figures for NH SPAC 8 (as of Nov 7, 2026): return on equity 245.3%, debt of 0.14 per unit of equity. They feed the Quality Score of 68/100, which measures business quality independently of the share price.
How far is 218410 from its 52-week high?
NH SPAC 8 trades at 37,200 KRW, about 67% below its 52-week high of 112,500 KRW and 45% above the low of 25,641 KRW (as of Nov 6, 2026). Distance from the high says nothing about value: that is what the fair value of 40,920 KRW is for.
Which stocks are comparable to NH SPAC 8?
From the same area (Technology) we also value JUSUNG ENGINEERING Co, PSK HOLDINGS Inc, ISC Co, TSE Co, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is NH SPAC 8 stock attractive at the current price?
The data as of Nov 7, 2026: price 37,200 KRW, calculated fair value 40,920 KRW (+10%), Quality Score 68/100, from 26 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of 218410 calculated?
We run NH SPAC 8 through 26 models from 8 families: DCF Models, Earnings-Based, Dividend Discount, Multiples, Asset-Based, Growth DCF, Economic Profit, Growth Earnings. Every model gets the same audited fundamentals; the fair value of 40,920 KRW builds on their evidence-weighted average, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 13.0% above its aggregate fair value. NH SPAC 8 currently trades 9% below its own fair value, and the market average says nothing about that. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of NH SPAC 8 (218410)?
The closing price on Nov 6, 2026 was 37,200 KRW. Our model-based fair value is 40,920 KRW, about +10% upside (fairly valued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with NH SPAC 8 right now?
The price sits close to our fair value, market and models broadly agree here, little valuation tension. A fairly wide model range (27,072 KRW to 53,953 KRW) leaves room in how you read the outcome.
Key figures of NH SPAC 8
How large is the market capitalisation of NH SPAC 8 (218410)?
The market capitalisation of NH SPAC 8 is 1.2T KRW (≈ $879M). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of NH SPAC 8 (218410)?
The price-to-sales ratio of NH SPAC 8 is 11.2 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What is the dividend yield of NH SPAC 8 (218410)?
The dividend yield of NH SPAC 8 is 0.5%. Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.
What is the net margin of NH SPAC 8 (218410)?
The net margin of NH SPAC 8 is 4.2% (last twelve months). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of NH SPAC 8 (218410)?
The return on equity (ROE) of NH SPAC 8 is 245% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of NH SPAC 8 (218410)?
On an EBIT basis the return on assets of NH SPAC 8 is 1.3% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of NH SPAC 8 (218410)?
The operating margin of NH SPAC 8 is 1.0% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at NH SPAC 8 (218410)?
Revenue at NH SPAC 8 is growing +53.5% versus a year earlier (3y avg +19.8%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at NH SPAC 8 (218410)?
Earnings per share at NH SPAC 8 are growing +11.0% versus a year earlier. How much earnings per share grew versus a year earlier.
How much net debt does NH SPAC 8 (218410) carry?
The net debt of NH SPAC 8 is 22.0B KRW (fiscal year 2023, ≈ 0.9 yrs of FCF). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed
Watch NH SPAC 8 in the live analysis
One click puts NH SPAC 8 on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.
Some data
Nov 7, 2026